How Much Does a GLP-1 Cost Without Insurance?

Most people shopping for a GLP-1 discover the same uncomfortable fact: their insurance does not cover weight-loss medication, or covers it only with prior authorizations they cannot clear. That leaves cash-pay — and the good news is that the cash-pay landscape in 2026 is nothing like the $1,000-plus retail sticker that scared everyone off two years ago. There are now three distinct ways to buy a GLP-1 without insurance, and they differ by hundreds of dollars a month. Here is what each really costs, and how to pay the least for the result you actually want.

Why is "without insurance" the normal case?

Weight-loss coverage is patchy. Many commercial plans exclude anti-obesity medication outright, Medicare's coverage of these drugs for weight loss is limited, and even covered patients often face step therapy or prior authorization. So a large share of GLP-1 users are, functionally, cash-pay. That is not a fringe situation to work around — it is the situation to plan for. See GLP-1 insurance coverage and prior authorization for authorization questions, and Medicare, Medicaid and HSA/FSA rules for current government coverage pathways, including the temporary Medicare GLP-1 Bridge for eligible beneficiaries. Coverage for another approved indication is a separate question; accurately document your diagnosis and intended use rather than assuming that an off-label prescription will be covered. Ozempic vs Wegovy explains why product and indication matter. The whole premise of our value leaderboard is ranking providers on what a self-pay patient truly spends over a year, not on an insurance-adjusted fantasy price.

Route 1: manufacturer self-pay (brand, FDA-approved)

The biggest change is that both major manufacturers now sell their branded drugs directly to cash patients, well below the old pharmacy list price. For Wegovy (semaglutide), Novo Nordisk's NovoCare self-pay price is $349 a month for the pen at every dose up to 2.4 mg and $399 at the 7.2 mg dose, and patients new to the program pay $199 a month for their first two fills of the 0.25 mg and 0.5 mg starting doses through December 31, 2026⁹. For Zepbound (tirzepatide), Eli Lilly's self-pay price starts at $299 a month for the 2.5 mg KwikPen or vial; the KwikPen's regular price then rises with the dose, to $399 at 5 mg, $499 at 7.5 mg and $699 at 10 mg and above, with a $449 purchase offer on the 7.5 mg to 15 mg KwikPen through December 31, 2026¹⁰. These programs carry eligibility rules and change their terms often, so check the price for your dose before your first fill. The government's TrumpRx site lists the same manufacturer cash prices, broken down dose by dose in TrumpRx GLP-1 prices. Both routes are the genuine FDA-approved product — the same molecule studied in the pivotal trials, where semaglutide 2.4 mg produced roughly 15% mean weight loss¹ and tirzepatide up to about 21% at its highest dose². The trade-off: brand self-pay is the most expensive of the three routes, and the vial formats can require a bit more handling than the autoinjector pens. Our brand-versus-compounded cost breakdown walks the full comparison, and Zepbound's cost, isolated lays out the manufacturer price alongside our brand-access partners and the cheaper compounded route.

Route 2: compounded GLP-1 via telehealth

Compounded semaglutide and tirzepatide, dispensed through telehealth providers, have been the cheapest route — with most published prices falling between about $99 and $269 a month for compounded semaglutide and about $145 and $359 for compounded tirzepatide, and a few programs listing lower (per each provider's published pricing). The important caveat is regulatory: after the FDA declared the semaglutide and tirzepatide shortages resolved, the broad legal basis for mass-compounding these molecules narrowed, and the compounded market has been shifting accordingly. Compounded products are also not FDA-approved and not reviewed for safety, efficacy, or quality the way the brand is. That does not make every compounded program a bad choice, but it does make provider vetting non-negotiable — start with is compounded semaglutide legit and safe before you buy on price alone, and use the full monthly cost guide for current numbers. At the low end of that band, Pepti starts semaglutide at $99 for a 28-day supply and publishes a price for every dose step up to $199, so budget for the dose you'll actually reach.

Route 3: telehealth memberships (watch the teaser)

Many telehealth brands wrap the medication in a membership — a monthly fee that bundles the prescription, clinician access, and coaching. The advertised entry price is frequently a teaser that steps up after month one, and the bundle can hide consult fees, lab charges, and coaching subscriptions you cannot cancel independently. The sticker is not the budget. Before you commit, run every finalist through the true monthly cost of GLP-1 and price the whole year, not the hook. The cost calculators do that arithmetic, and the compare tool lines finalists up on the honest number. Check the shape of the plan as well as its price: one program on our bench sells a single GLP-1 price every four weeks and lets the provider choose semaglutide or tirzepatide without saying what tirzepatide costs, which is a different purchase from a per-drug price.

The number that changes everything: this is an annual purchase

Here is the value insight that reframes the entire "without insurance" question. A GLP-1 is not a one-time buy — the benefit depends on staying on it. When treatment is stopped, the weight tends to come back: in the semaglutide withdrawal trial, people who switched to placebo regained a substantial share of their lost weight⁵, and the tirzepatide withdrawal trial showed the same pattern⁶. Continued treatment, by contrast, sustains the loss over years⁷. So the honest cash-pay math is not "what does one month cost" but "what does twelve months cost, from a provider I can actually stay with." A $99 teaser you abandon by spring buys you regain; a slightly higher flat price you can sustain for a year buys you the result. That is exactly what the Cost-Efficiency Index is built to measure.

How can you pay the least without gambling on quality?

Four moves, in order. First, decide molecule by value, not hype — tirzepatide leads on average weight loss but semaglutide is usually cheaper, and our semaglutide vs tirzepatide value guide helps you weigh the trade. Second, get the manufacturer self-pay price as your FDA-approved benchmark, then see whether a verified telehealth or compounded route beats it enough to matter. Third, compute the true annual cost for every finalist — month-one plus eleven maintenance months plus fees — not the intro sticker. Fourth, favor a flat-price, transparently-run provider like CoreAge Rx so month twelve costs the same as month one. Do those four and the "cheapest" option on the landing page is frequently not the cheapest once the year is priced honestly.

Is there a cheaper oral option?

The Wegovy pill is another FDA-approved option to price. The Wegovy pill is FDA-approved for weight reduction as a once-daily tablet, starting at 1.5 mg and stepping up every 30 days to a 25 mg maintenance dose¹¹. NovoCare's self-pay price follows the dose: $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg⁹. That makes the pill's maintenance dose cheaper than the Wegovy pen at self-pay, with no needle or refrigerator, though it has to be taken on an empty stomach with a 30-minute wait before eating. Earlier phase 3 work with a higher-dose oral semaglutide showed the tablet route can produce meaningful weight loss³. See Wegovy pill cost for the 30-tablet supply basis, savings limits and separate care fees, and the Wegovy pill: dose, cost and how it differs from Rybelsus for the full schedule. GLP-1s have also shown cardiovascular benefit in people with obesity and established heart disease⁴, and tirzepatide's edge over a semaglutide comparator in a head-to-head diabetes trial⁸ is part of why the efficacy-versus-price trade is worth doing deliberately. The trials and pricing sources behind all of this are indexed in our research library. For now, price your own year across all three routes and compare on the number you will really pay. Our cheapest GLP-1 list shows each provider's monthly price, and the cheapest GLP-1 over 12 months list shows the full-year figure (partners are listed first on both).